Microsatellite alleles and single nucleotide polymorphisms (SNP) combine to form four major haplotype families at the human interleukin-10 (IL-10) locus

Genes and Immunity

Volumn 1, Issue 2, 1999, Pages 151-155

  Eskdale, J ^a   Keijsers, V ^b   Huizinga, T ^b   Gallagher, G ^a  

^a UNIVERSITY OF GLASGOW   (United Kingdom)

^b LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

Cytokine secretion; Haplotype; IL 10; Interleukin; Polymorphism

Indexed keywords

CYTOKINE; INTERLEUKIN 10; MICROSATELLITE DNA;

ALLELE; ARTICLE; GENETICS; HAPLOTYPE; HUMAN; NETHERLANDS; SECRETION; SINGLE NUCLEOTIDE POLYMORPHISM;

ALLELES; CYTOKINES; HAPLOTYPES; HUMANS; INTERLEUKIN-10; MICROSATELLITE REPEATS; NETHERLANDS; POLYMORPHISM, SINGLE NUCLEOTIDE;

EID: 0033224336     PISSN: 14664879     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.gene.6363656     Document Type: Article

References (24)

1. Moore KW, O'Garra A, de Waal-Malefyt R, Viera P, Mosmann TR. IL-10 Ann Rev Immunol 1993; 11: 165-290.
2. Malefyt RD, Abrams J, Bennet B, Figdor CG, de Vries JE. Interleukin 10 (IL-10) inhibits cytokine synthesis by human monocytes: an autoregulatory role of IL-10 produced by monocytes. J Expl Med 1991; 174; 1209-1220.
3. Wanidworanun C, Strober W. Predominant role of tumour necrosis factor-α in human monocyte IL-10synthesis. J Immunol 1993; 151: 6853-6861.
4. Llorente L, Richard-Patin Y, Fior R et al. In vivo production of interleukin-10 by non-T-cells in rheumatoid arthritis, Sjogren's syndrome and systemic lupus erythematosus. Arth Rheum 1994; 37: 1647-1655.
5. Cash JJ, Splawski JB, Thomas R et al. Elevated levels of interleukin-10 in patients with rheumatoid arthritis. Arth Rheum 1995; 38: 96-104.
6. Perez L, Orte J, Brieva JA. Terminal differentiation of spontaneous rheumatoid factor-secreting B-cells from rheumatoid arthritis patients depends on endogenus interleukin-10. Arth Rheum 1995; 38: 1771-1776.
7. Itoh K, Hirohata S. The role of IL-10 in human B-cell activation, proliferation and differentiation. J Immunol 1995; 154:4341-4350.
8. Llorente L, Zou W, Levy Y et al. Role of interleukin-10 in the B-lymphocyte hyperactivity and autoantibody production of human systemic lupus erythematosus. J Expl Med 1995; 181: 839-844.
9. Luscher U, Filgueira L, Juretic A et al. The pattern of cytokine gene expression in freshly excised human metastatic melanoma suggests a state of reversible anergy of tumour infiltrating lymphocytes. Intl J Cancer 1994; 57: 612-619.
10. Matsuda MF, Salazar F, Petersson M et al. Interleukin-10 protects target cells from tumour specific and allospecific cytotoxic T-cells by down-regulating HLA class-I expression. J Expl Med 1994; 180: 2371-2376.
11. Kim J, Modlin RL, Moy RL et al. Interleukin-10 production in cutaneous basal and squamous cell carcinomas: a model for evading the local T-cell immune response. J Imunol 1995; 155: 2240-2247.
12. Suzuki T, Tahara H, Narula S, Moore KW, Robbins PD, Lotze MT. Viral interleukin-10 (IL-10), the human herpes-virus-4 cellular IL-10 homolog, induces local anergy to allogeneic and syngeneic tumours. J Expl Med 1995; 182: 447-486.
13. Fortis C, Foppoli M, Gianotti L et al. Increased interleukin-10 levels in the serum of patients with solid tumours. Cancer Lett 1996; 104: 1-5.
14. Murray PJ, Wang L, Onufry RC, Tepper RI, Young RA. T cell-derived IL-10 antagonizes macrophage function in mycobacterial infection. J Immunol 1997; 158: 315-231.
15. Derkx B, Marchant A, Goldman M, Bijlmer R, de Ventner S. High levels of interleukin-10 during the initial phase of fulminant meningococcal septic shock. J Infect Dis 1995; 171: 229-239.
16. Lehmann AK, Halstenen A, Sornes S, Rokke O, Waage A. High levels of interleukin 10 in serum are associated with fatality in meningococcal disease. Infect Immun 1995; 63: 2109-2112.
17. Westendorp RGJ, Langermans JAM, Huizinga TWG, Elouali AH, Verweij CL, Vandenbroucke JP. Genetic influence on cytokine production and fatal meningococcal disease. Lancet 1997; 349: 170-173.
18. Eskdale J, Gallagher G, Verweij CL, Keijsers V, Westendorp RG, Huizinga TW. Interleukin 10 secretion in relation to human IL-10 locus haplotypes. Proc Natl Acad Sci USA 1998; 95: 9465-9470.
19. Eskdale J, Gallagher G. A polymorphic dinucleotide repeat in the human IL-10 promoter. Immunogenetics 1995; 42: 444-445.
20. Eskdale J, Kube D, Gallagher G. A second polymorphic dinucleotide repat in the 5′ flanking region of the human IL-10 gene. Immunogenetics 1996; 45: 82-83.
21. Eskdale J, Kube D, Tesch H, Gallagher G. Mapping of the human IL10 gene and further characterization of the 5′ flanking sequence. Immunogenetics 1997; 46: 120-128.
22. Turner DM, Williams DM, Sankaran D, Lazarus M, Sinnott PJ, Hutchinson IV. An investigation of polymorphism in the interleukin-10 gene promoter. Eur J Immunogenet 1997; 24: 1-8.
23. Mok CC, Lanchbury JS, Chan DW, Lau CS. Interleukin-10 promoter polymorphisms in Southern Chinese patients with systemic lupus erythematosus. Arthritis Rheum 1998; 41: 1090-1095.
24. Kim TG, Han H. Polymorphism of human interleukin 10 promoter in Koreans. GenBank, Accession number, AF083251, 1999.